NCT01075945Unknown4 期
Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 入组人数
- 140
- 试验地点
- 1
- 主要终点
- comparing the cure rate between the two drugs
研究概览
简要总结
Dihydroartemisinin- Piperaquine is not inferior to artemether-lumefantrine
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 5 Years 至 95 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Uncomplicated malaria
排除标准
- •Severe cases
- •Pregnancy
研究组 & 干预措施
Dihydroartemisinin- piperaquine
Experimental
orally tablets
干预措施: Dihydroartemisinin- piperaquine (Drug)
Dihydroartemisinin- piperaquine
Experimental
orally tablets
干预措施: artemether- lumefantrine (Drug)
artemether- lumefantrine
Active Comparator
oral tablets
干预措施: artemether- lumefantrine (Drug)
结局指标
主要结局
comparing the cure rate between the two drugs
时间窗: 3 months
PCR cure rate Parasite clearance time Fever clearance time
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Comparison of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for treatment of uncomplicated malaria in Uganda: evaluation of efficacy, safety, and tolerabilityISRCTN75606663ganda Malaria Surveillance Project (Uganda)400
已完成
4 期
Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi NigerMalariaNCT01755559Epicentre663
已完成
不适用
To compare the response of children with sickle cell disease (SCD) and malaria to artemisinin combination therapy (ACT) antimalarials and the response of children without SCD treated with ACT for malariaSickle cell disease/malariaInfections and InfestationsPlasmodium falciparum malariaISRCTN96891086Danida Fellowship Centre (Denmark)120
尚未招募
3 期
Chemoprevention of malaria and other infectious disease in the post-discharge management of children with severe anaemia in Malawi, Kenya and UgandaMalariaPACTR202303630742194Training and Research Unit of Excellence958
招募中
4 期
Efficacy and safety of artemether+lumefantrine & dihydroartemisinin+piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in different sentinel site in SudaMalariaACTRN12617000276358Federal Ministry of Health440